We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sponsors of CID Trials Should Discuss Plans With the FDA, Guidance Says
Sponsors of CID Trials Should Discuss Plans With the FDA, Guidance Says
Before proceeding with trials that use complex innovative designs (CID), sponsors should meet with the FDA to discuss their plans, according to a final guidance released Wednesday that provides details on the kinds of information to bring to an agency meeting.